Adarza BioSystems is a series c plus startup. 2 investors tracked. Status: possibledead.
Based in the United States, Adarza BioSystems is a startup. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Adarza BioSystems develops advanced bioanalytical instrumentation for protein biomarker discovery and clinical diagnostics, specializing in label-free and multiplexed immunoassay technologies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.